Expand BIAFW Menu
BIAFW MENU

BIAFW Latest Press Releases

-- April 28, 2026 --

bioAffinity Technologies Launches New Study To Expand Use of CyPath Lung Technology for Asthma and COPD Diagnosis and Treatment Business Wire 9:16 AM

-- April 14, 2026 --

New Case Study: bioAffinity Technologies' CyPath Lung Diagnostic Supports Physician's Assessment, Prompts Follow-Up Imaging and Defers Unnecessary Biopsy Business Wire 8:00 AM

-- April 7, 2026 --

bioAffinity Technologies' CyPath Lung to Be Featured at Cleveland Clinic Annual "Advances in Early Lung Cancer Detection" Symposium April 16 Business Wire 8:00 AM

-- April 1, 2026 --

bioAffinity Technologies' CyPath Lung Test Unit Sales Surged 146% Year-Over-Year in Q1 2026 Business Wire 8:00 AM

-- March 25, 2026 --

bioAffinity Technologies to Host Live Virtual Physician Roundtable on Integrating CyPath Lung into Pulmonary Practice Business Wire 8:00 AM

-- March 17, 2026 --

New Case Study: bioAffinity Technologies' CyPath Lung Provides Actionable Results and Helps Patient Avoid Costly, Invasive Procedures Business Wire 7:45 AM

-- March 13, 2026 --

bioAffinity Technologies Announces Record 2025 Revenue and Unit Sales for Flagship Lung Cancer Diagnostic CyPath Lung Business Wire 8:00 AM

-- March 10, 2026 --

bioAffinity Technologies Announces Initiation of Large-Scale Longitudinal Clinical Study for Its Noninvasive CyPath Lung Cancer Diagnostic Business Wire 7:47 AM

-- March 3, 2026 --

bioAffinity Technologies Presents Positive Research Findings for its Novel Diagnostic Platform Technology to Identify Optimal Therapies for Asthma Patients Business Wire 8:30 AM

-- February 25, 2026 --

bioAffinity Technologies Announces Validation Study with Brooke Army Medical Center to Expand Sample Collection Options for the CyPath Lung Noninvasive Early Detection Lung Cancer Test Business Wire 8:30 AM

-- February 19, 2026 --

New Case Study Highlights Ability of bioAffinity Technologies' CyPath Lung to Reduce Diagnostic Burden for Patients At Risk for Lung Cancer Business Wire 11:00 AM

-- February 17, 2026 --

Clinical Utility of bioAffinity Technologies' CyPath Lung Test Demonstrated in Real-World Case Study Business Wire 8:00 AM

-- February 9, 2026 --

bioAffinity Technologies Appoints Nationally Recognized Pulmonary and Lung Cancer Authorities to its Medical and Scientific Advisory Board Business Wire 8:00 AM

-- January 7, 2026 --

bioAffinity Technologies' Laboratory Maintains Prestigious College of American Pathologists (CAP) Accreditation Business Wire 8:00 AM

-- December 3, 2025 --

bioAffinity Technologies' Noninvasive CyPath Lung Test to Be Highlighted at American Cancer Society National Lung Cancer Roundtable Business Wire 8:00 AM
Market Data Delayed 15 Minutes